{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T01:26:46Z","timestamp":1794878806244,"version":"4.9.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-026-26876-6","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:46:49Z","timestamp":1773812809000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between access to care and direct healthcare costs in people with and at high-risk of chronic kidney disease in the United States: a pooled cross-sectional study using the Medical Expenditure Panel Survey"],"prefix":"10.1186","volume":"26","author":[{"given":"Satabdi","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Flottemesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay G. S.","family":"Bengtson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelby L.","family":"Corman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie M. K.","family":"Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"26876_CR1","unstructured":"United States Renal Data System. 2023 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2023."},{"issue":"4","key":"26876_CR2","first-page":"312","volume":"15","author":"F Lalibert\u00e9","year":"2009","unstructured":"Lalibert\u00e9 F, Bookhart BK, Vekeman F, Corral M, Duh MS, Bailey RA, et al. Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective. J Manag Care Pharm. 2009;15(4):312\u201322.","journal-title":"J Manag Care Pharm"},{"key":"26876_CR3","doi-asserted-by":"publisher","first-page":"1499225","DOI":"10.3389\/fmed.2024.1499225","volume":"11","author":"M Zhuang","year":"2024","unstructured":"Zhuang M, Lv X, Zhu Y, Zheng N, Zhan Y. Trends in the prevalence of chronic kidney disease in the United States, 1999-2018. Front Med-Lausanne-. 2024;11:1499225.","journal-title":"Front Med-Lausanne-"},{"issue":"2","key":"26876_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/1753-0407.12616","volume":"10","author":"Z Bloomgarden","year":"2018","unstructured":"Bloomgarden Z. The kidney and cardiovascular outcome trials. J Diabetes. 2018;10(2):88\u20139.","journal-title":"J Diabetes"},{"key":"26876_CR5","unstructured":"Pavkov ME, Collins AJ, Coresh J, Nelson RG. Kidney Disease in Diabetes. In: Cowie CC, Casagrande SS, Menke A, Cissell MA, Eberhardt MS, Meigs JB, et al., editors. Diabetes in America. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018."},{"issue":"4","key":"26876_CR6","first-page":"e24244","volume":"14","author":"E Habas Sr","year":"2022","unstructured":"Habas E Sr, Habas E, Khan FY, Rayani A, Habas A, Errayes M, et al. Blood pressure and chronic kidney disease progression: An updated review. Cureus. 2022;14(4):e24244.","journal-title":"Cureus"},{"issue":"6","key":"26876_CR7","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1161\/HYPERTENSIONAHA.119.12697","volume":"73","author":"R Aggarwal","year":"2019","unstructured":"Aggarwal R, Petrie B, Bala W, Chiu N. Mortality outcomes with intensive blood pressure targets in chronic kidney disease patients. Hypertension. 2019;73(6):1275\u201382.","journal-title":"Hypertension"},{"issue":"16","key":"26876_CR8","doi-asserted-by":"publisher","first-page":"e012749","DOI":"10.1161\/JAHA.119.012749","volume":"8","author":"E Ku","year":"2019","unstructured":"Ku E, Sarnak MJ, Toto R, McCulloch CE, Lin F, Smogorzewski M, et al. Effect of blood pressure control on long-term risk of end-stage renal disease and death among subgroups of patients with chronic\u00a0kidney disease. J Am Heart Assoc. 2019;8(16):e012749.","journal-title":"J Am Heart Assoc"},{"key":"26876_CR9","unstructured":"Office of Disease Prevention and Health Promotion. Healthy People 2030: Building a Healthier Future. In: (CDC) CfDCaP, editor.: Office of Disease Prevention and Health Promotion 2020."},{"issue":"1","key":"26876_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1053\/j.ackd.2014.07.002","volume":"22","author":"SB Nicholas","year":"2015","unstructured":"Nicholas SB, Kalantar-Zadeh K, Norris KC. Socioeconomic disparities in chronic kidney disease. Adv Chronic Kidney Dis. 2015;22(1):6\u201315.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"5","key":"26876_CR11","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.semnephrol.2013.07.008","volume":"33","author":"DC Crews","year":"2013","unstructured":"Crews DC, Pfaff T, Powe NR. Socioeconomic factors and racial disparities in kidney disease outcomes. Semin Nephrol. 2013;33(5):468\u201375.","journal-title":"Semin Nephrol"},{"issue":"16","key":"26876_CR12","doi-asserted-by":"publisher","first-page":"e034996","DOI":"10.1161\/JAHA.124.034996","volume":"13","author":"J Li","year":"2024","unstructured":"Li J, Lei L, Wang W, Ding W, Yu Y, Pu B, et al. Social risk profile and cardiovascular-kidney-metabolic syndrome in US adults. J Am Heart Assoc. 2024;13(16):e034996.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"26876_CR13","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.2105\/AJPH.2014.302048","volume":"105","author":"DR Buys","year":"2015","unstructured":"Buys DR, Howard VJ, McClure LA, Buys KC, Sawyer P, Allman RM, et al. Association between neighborhood disadvantage and hypertension prevalence, awareness, treatment, and control in older adults: results from the University of Alabama at Birmingham Study of Aging. Am J Public Health. 2015;105(6):1181\u20138.","journal-title":"Am J Public Health"},{"issue":"7","key":"26876_CR14","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jamacardio.2017.1658","volume":"2","author":"A Odutayo","year":"2017","unstructured":"Odutayo A, Gill P, Shepherd S, Akingbade A, Hopewell S, Tennankore K, et al. Income disparities in absolute cardiovascular risk and cardiovascular risk factors in the United States, 1999\u20132014. JAMA Cardiol. 2017;2(7):782\u201390.","journal-title":"JAMA Cardiol"},{"key":"26876_CR15","doi-asserted-by":"publisher","first-page":"E109","DOI":"10.5888\/pcd20.230065","volume":"20","author":"ML Sells","year":"2023","unstructured":"Sells ML, Blum E, Perry GS, Eke P, Presley-Cantrell L. Excess burden of poverty and hypertension, by race and ethnicity, on the prevalence of cardiovascular disease. Prev Chronic Dis. 2023;20:E109.","journal-title":"Prev Chronic Dis"},{"issue":"11","key":"26876_CR16","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1038\/s41440-021-00739-6","volume":"44","author":"N Chiu","year":"2021","unstructured":"Chiu N, Lauffenburger JC, Franklin JM, Choudhry NK. Prevalence, predictors, and outcomes of both true- and pseudo-resistant hypertension in the action to control cardiovascular risk in diabetes trial: a cohort study. Hypertens Res. 2021;44(11):1471\u201382.","journal-title":"Hypertens Res"},{"issue":"5","key":"26876_CR17","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/dom.13625","volume":"21","author":"W Fan","year":"2019","unstructured":"Fan W, Song Y, Inzucchi SE, Sperling L, Cannon CP, Arnold SV, et al. Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: the diabetes collaborative registry. Diabetes Obes Metab. 2019;21(5):1121\u20137.","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"26876_CR18","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.122.20219","volume":"80","author":"OP Akinyelure","year":"2023","unstructured":"Akinyelure OP, Jaeger BC, Oparil S, Carson AP, Safford MM, Howard G, et al. Social determinants of health and uncontrolled blood pressure in a national cohort of Black and White US adults: the REGARDS study. Hypertension. 2023;80(7):1403\u201313.","journal-title":"Hypertension"},{"issue":"5","key":"26876_CR19","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3122\/jabfm.2023.230498R2","volume":"37","author":"JL Sosso","year":"2024","unstructured":"Sosso JL, Fischer KM, Lampman MA, Garrison GM, Stacey SK, Bernard ME, et al. Relationship between social risks and diabetes metrics in a US Health system. J Am Board Fam Med. 2024;37(5):939\u201347.","journal-title":"J Am Board Fam Med"},{"key":"26876_CR20","doi-asserted-by":"publisher","first-page":"100939","DOI":"10.1016\/j.ajpc.2025.100939","volume":"21","author":"F Golden","year":"2025","unstructured":"Golden F, Tran J, Wong ND. Composite cardiovascular risk factor control in US adults with diabetes and relation to social determinants of health: the All of Us research program. Am J Prev Cardiol. 2025;21:100939.","journal-title":"Am J Prev Cardiol"},{"key":"26876_CR21","doi-asserted-by":"publisher","first-page":"672350","DOI":"10.3389\/fendo.2021.672350","volume":"12","author":"Y Deng","year":"2021","unstructured":"Deng Y, Li N, Wu Y, Wang M, Yang S, Zheng Y, et al. Global, regional, and national burden of diabetes-related chronic kidney disease From 1990 to 2019. Front Endocrinol (Lausanne). 2021;12:672350.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"26876_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1471-2369-15-136","volume":"15","author":"SA Fedewa","year":"2014","unstructured":"Fedewa SA, McClellan WM, Judd S, Guti\u00e9rrez OM, Crews DC. The association between race and income on risk of mortality in patients with moderate chronic kidney disease. BMC Nephrol. 2014;15:136.","journal-title":"BMC Nephrol"},{"issue":"1","key":"26876_CR23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/hdi.12325","volume":"20","author":"BH Garrity","year":"2016","unstructured":"Garrity BH, Kramer H, Vellanki K, Leehey D, Brown J, Shoham DA. Time trends in the association of ESRD incidence with area-level poverty in the US population. Hemodial Int. 2016;20(1):78\u201383.","journal-title":"Hemodial Int"},{"issue":"19","key":"26876_CR24","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1001\/jama.2023.5965","volume":"329","author":"TA LaVeist","year":"2023","unstructured":"LaVeist TA, P\u00e9rez-Stable EJ, Richard P, Anderson A, Isaac LA, Santiago R, et al. The Economic Burden of Racial, Ethnic, and Educational Health Inequities in the US. JAMA. 2023;329(19):1682\u201392.","journal-title":"JAMA"},{"issue":"1","key":"26876_CR25","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s12913-017-2303-3","volume":"17","author":"MN Ozieh","year":"2017","unstructured":"Ozieh MN, Bishu KG, Dismuke CE, Egede LE. Trends in healthcare expenditure in United States adults with chronic kidney disease: 2002-2011. BMC Health Serv Res. 2017;17(1):368.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"26876_CR26","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1186\/s12913-016-1922-4","volume":"16","author":"P Damien","year":"2016","unstructured":"Damien P, Lanham HJ, Parthasarathy M, Shah NL. Assessing key cost drivers associated with caring for chronic kidney disease patients. BMC Health Serv Res. 2016;16(1):690.","journal-title":"BMC Health Serv Res"},{"key":"26876_CR27","doi-asserted-by":"crossref","unstructured":"Research Priorities for Kidney-Related Research-An Agenda to Advance Kidney Care: A Position Statement From the National Kidney Foundation. Am J Kidney Dis. 2022;79(2):141\u201352.","DOI":"10.1053\/j.ajkd.2021.08.018"},{"key":"26876_CR28","unstructured":"Quality AfHRa. 1996\u20132023 Pooled Linkage Variance Estimation File2025 9\/1\/2025. Available from: https:\/\/meps.ahrq.gov\/data_stats\/download_data\/pufs\/h036\/h36u23doc.pdf."},{"key":"26876_CR29","unstructured":"Quality AfHRa. Using Statistical Software Packages to Produce Estimates from MEPS Data File; HC-147. Available from: https:\/\/meps.ahrq.gov\/survey_comp\/hc_samplecodes_se.pdf."},{"key":"26876_CR30","unstructured":"Agency for Healthcare Research and Quality (AHRQ). Medical Expenditure Survey (MEPS) Household Component (HC) Agency for Healthcare Research and Quality Department of Health and Human Services; [Available from: https:\/\/meps.ahrq.gov\/mepsweb\/survey_comp\/household.jsp."},{"key":"26876_CR31","unstructured":"Medical expenditure panel survey summary data technical notes. U.S. Department of Health & Human Services. 2025. Available from: https:\/\/meps.ahrq.gov\/survey_comp\/hc_technical_notes.shtml."},{"issue":"1","key":"26876_CR32","first-page":"55","volume":"10","author":"R Nee","year":"2017","unstructured":"Nee R, Yuan CM, Hurst FP, Jindal RM, Agodoa LY, Abbott KC. Impact of poverty and race on pre-end-stage renal disease care among dialysis patients in the United States. Clin Kidney J. 2017;10(1):55\u201361.","journal-title":"Clin Kidney J"},{"issue":"4","key":"26876_CR33","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.6139","volume":"4","author":"LA Eberly","year":"2021","unstructured":"Eberly LA, Yang L, Eneanya ND, Essien U, Julien H, Nathan AS, et al. Association of race\/ethnicity, gender, and socioeconomic status with sodium-glucose cotransporter 2 inhibitor use among patients with diabetes in the US. JAMA Netw Open. 2021;4(4):e216139.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"26876_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s41043-023-00459-2","volume":"42","author":"CM Studer","year":"2023","unstructured":"Studer CM, Linder M, Pazzagli L. A global systematic overview of socioeconomic factors associated with antidiabetic medication adherence in individuals with type 2 diabetes. J Health Popul Nutr. 2023;42(1):122.","journal-title":"J Health Popul Nutr"},{"issue":"1","key":"26876_CR35","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1053\/j.ackd.2014.06.003","volume":"22","author":"R Greer","year":"2015","unstructured":"Greer R, Boulware LE. Reducing CKD risks among vulnerable populations in primary care. Adv Chronic Kidney Dis. 2015;22(1):74\u201380.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"1","key":"26876_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.21037\/cdt-22-566","volume":"13","author":"CS Walker","year":"2023","unstructured":"Walker CS, Gadegbeku CA. Addressing kidney health disparities with new national policy: the time is now. Cardiovasc Diagn Ther. 2023;13(1):115\u201321.","journal-title":"Cardiovasc Diagn Ther"},{"issue":"9","key":"26876_CR37","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2021.2375","volume":"2","author":"MB Cole","year":"2021","unstructured":"Cole MB, Kim JH, Levengood TW, Trivedi AN. Association of Medicaid expansion with 5-year changes in hypertension and diabetes outcomes at federally qualified health centers. JAMA Health Forum. 2021;2(9):e212375.","journal-title":"JAMA Health Forum"},{"key":"26876_CR38","doi-asserted-by":"publisher","DOI":"10.1177\/21501319231195697","volume":"14","author":"N Huguet","year":"2023","unstructured":"Huguet N, Green BB, Larson AE, Moreno L, DeVoe JE. Diabetes and hypertension prevention and control in community health centers: impact of the Affordable Care Act. J Prim Care Community Health. 2023;14:21501319231195697.","journal-title":"J Prim Care Community Health"},{"issue":"4","key":"26876_CR39","doi-asserted-by":"publisher","first-page":"100424","DOI":"10.1016\/j.xkme.2022.100424","volume":"4","author":"SM Toth-Manikowski","year":"2022","unstructured":"Toth-Manikowski SM, Hsu JY, Fischer MJ, Cohen JB, Lora CM, Tan TC, et al. Emergency department\/urgent care as usual source of care and clinical outcomes in CKD: findings from the Chronic Renal Insufficiency Cohort Study. Kidney Med. 2022;4(4):100424.","journal-title":"Kidney Med"},{"issue":"12","key":"26876_CR40","doi-asserted-by":"publisher","first-page":"e041149","DOI":"10.1136\/bmjopen-2020-041149","volume":"10","author":"YC Chen","year":"2020","unstructured":"Chen YC, Weng SF, Hsu YJ, Wei CJ, Chiu CH. Continuity of care: evaluating a multidisciplinary care model for people with early CKD via a nationwide population-based longitudinal study. BMJ Open. 2020;10(12):e041149.","journal-title":"BMJ Open"},{"issue":"3","key":"26876_CR41","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1370\/afm.2813","volume":"20","author":"C Chong","year":"2022","unstructured":"Chong C, Campbell D, Elliott M, Aghajafari F, Ronksley P. Determining the association between continuity of primary care and acute care use in chronic kidney disease: a retrospective cohort study. Ann Fam Med. 2022;20(3):237\u201345.","journal-title":"Ann Fam Med"},{"key":"26876_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17082711","author":"NG Choi","year":"2020","unstructured":"Choi NG, DiNitto DM, Choi BY. Unmet healthcare needs and healthcare access gaps among uninsured U.S. adults aged 50-64. Int J Environ Res Public Health. 2020. https:\/\/doi.org\/10.3390\/ijerph17082711.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"26876_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.amepre.2021.02.014","volume":"61","author":"KR Yabroff","year":"2021","unstructured":"Yabroff KR, Zhao J, Halpern MT, Fedewa SA, Han X, Nogueira LM, et al. Health insurance disruptions and care access and affordability in the U.S. Am J Prev Med. 2021;61(1):3\u201312.","journal-title":"Am J Prev Med"},{"issue":"1","key":"26876_CR44","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12913-019-4124-z","volume":"19","author":"V Seo","year":"2019","unstructured":"Seo V, Baggett TP, Thorndike AN, Hull P, Hsu J, Newhouse JP, et al. Access to care among Medicaid and uninsured patients in community health centers after the Affordable Care Act. BMC Health Serv Res. 2019;19(1):291.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"26876_CR45","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1053\/j.ackd.2014.05.006","volume":"22","author":"DS Tuot","year":"2015","unstructured":"Tuot DS, Grubbs V. Chronic kidney disease care in the US safety net. Adv Chronic Kidney Dis. 2015;22(1):66\u201373.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"4","key":"26876_CR46","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.ekir.2023.01.037","volume":"8","author":"JJ Garcia Sanchez","year":"2023","unstructured":"Garcia Sanchez JJ, James G, Carrero JJ, Arnold M, Lam CSP, Pollock C, et al. Health care resource utilization and related costs of patients with CKD from the United States: a report from the DISCOVER CKD retrospective cohort. Kidney Int Rep. 2023;8(4):785\u201395.","journal-title":"Kidney Int Rep"},{"issue":"1","key":"26876_CR47","first-page":"80","volume":"29","author":"H Chung","year":"2023","unstructured":"Chung H, Crowe CL, Kong SX, Singh R, Farej R, Elliott J, et al. Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population. J Manag Care Spec Pharm. 2023;29(1):80\u20139.","journal-title":"J Manag Care Spec Pharm"},{"issue":"6 Suppl","key":"26876_CR48","first-page":"S112","volume":"28","author":"KA Betts","year":"2022","unstructured":"Betts KA, Song J, Elliott J, Warnock N, Farej R, Wu A, et al. Geographical variation in kidney function testing and associations with health care costs among patients with chronic kidney disease and type 2 diabetes. Am J Manag Care. 2022;28(6 Suppl):S112\u20139.","journal-title":"Am J Manag Care"},{"key":"26876_CR49","unstructured":"Centers for Medicare & Medicaid Services. Medicare's Coverage of Kidney Dialysis & Kidney Transplant Benefits Available from: https:\/\/www.medicare.gov\/publications\/11360-medicare-dialysis-kidney-transplant.pdf."},{"issue":"1","key":"26876_CR50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12882-016-0432-2","volume":"18","author":"C Small","year":"2017","unstructured":"Small C, Kramer HJ, Griffin KA, Vellanki K, Leehey DJ, Bansal VK, et al. Non-dialysis dependent chronic kidney disease is associated with high total and out-of-pocket healthcare expenditures. BMC Nephrol. 2017;18(1):3.","journal-title":"BMC Nephrol"},{"key":"26876_CR51","unstructured":"Machlin SR, Dougherty DD. Overview of Methodology for Imputing Missing Expenditure Data in the Medical Expenditure Panel Survey. Methodology Report No. 19. March 2007 Rockville, MD: Agency for Healthcare Research and Quality; Available from: https:\/\/meps.ahrq.gov\/data_files\/publications\/mr19\/mr19.shtml."},{"issue":"11","key":"26876_CR52","doi-asserted-by":"publisher","first-page":"e0293912","DOI":"10.1371\/journal.pone.0293912","volume":"18","author":"L Adjeroh","year":"2023","unstructured":"Adjeroh L, Brothers T, Shawwa K, Ikram M, Al-Mamun MA. The association between polypharmacy and health-related quality of life among non-dialysis chronic kidney disease patients. PLoS ONE. 2023;18(11):e0293912.","journal-title":"PLoS ONE"},{"issue":"1","key":"26876_CR53","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.diabres.2015.04.011","volume":"109","author":"MN Ozieh","year":"2015","unstructured":"Ozieh MN, Dismuke CE, Lynch CP, Egede LE. Medical care expenditures associated with chronic kidney disease in adults with diabetes: United States 2011. Diabetes Res Clin Pract. 2015;109(1):185\u201390.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"26876_CR54","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1186\/s12913-016-1844-1","volume":"16","author":"MN Ozieh","year":"2016","unstructured":"Ozieh MN, Bishu KG, Walker RJ, Campbell JA, Egede LE. Geographic variation in access among adults with kidney disease: evidence from medical expenditure panel survey, 2002-2011. BMC Health Serv Res. 2016;16(1):585.","journal-title":"BMC Health Serv Res"},{"issue":"10","key":"26876_CR55","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1007\/s12325-023-02608-9","volume":"40","author":"V Jha","year":"2023","unstructured":"Jha V, Al-Ghamdi SMG, Li G, Wu MS, Stafylas P, Retat L, et al. Global economic burden associated with chronic kidney disease: a pragmatic review of medical costs for the inside CKD research programme. Adv Ther. 2023;40(10):4405\u201320.","journal-title":"Adv Ther"},{"issue":"20 Suppl","key":"26876_CR56","first-page":"S369","volume":"27","author":"KA Betts","year":"2021","unstructured":"Betts KA, Song J, Faust E, Yang K, Du Y, Kong SX, et al. Medical costs for managing chronic kidney disease and related complications in patients with chronic kidney disease and type 2 diabetes. Am J Manag Care. 2021;27(20 Suppl):S369\u201374.","journal-title":"Am J Manag Care"},{"issue":"5","key":"26876_CR57","doi-asserted-by":"publisher","first-page":"e067386","DOI":"10.1136\/bmjopen-2022-067386","volume":"13","author":"N Tangri","year":"2023","unstructured":"Tangri N, Moriyama T, Schneider MP, Virgitti JB, De Nicola L, Arnold M, et al. Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD study. BMJ Open. 2023;13(5):e067386.","journal-title":"BMJ Open"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-26876-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-26876-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-26876-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T02:02:30Z","timestamp":1777255350000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-26876-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["26876"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-26876-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7190552\/v1","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study data were obtained from the Medical Expenditure Panel Survey (MEPS) which is publicly available without patient, physician, and facility identifiers. All authors meet criteria for authorship as recommended by the ICMJE.\u200b None of the authors received payment related to the development of the manuscript.\u200b","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"S Chatterjee, LGS Bengtson, and BMK Donato are employees of Boehringer Ingelheim Pharmaceuticals Inc. T Flottemesch and S Corman are employees of Precision AQ, which received funds from Boehringer Ingelheim Pharmaceuticals, Inc. to conduct this project.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1368"}}